AngioDynamics, Inc. (FRA:UG2)

Market Cap	460.01M
Revenue (ttm)	257.08M
Net Income (ttm)	-27.44M
Shares Out	n/a
EPS (ttm)	-0.67
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	84
Open	10.50
Previous Close	10.50
Day's Range	10.50 - 10.50
52-Week Range	6.25 - 12.80
Beta	n/a
RSI	55.09
Earnings Date	Jan 6, 2026

About AngioDynamics

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device tha...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1988
• Employees: 675
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UG2

Financial Performance

In 2025, AngioDynamics's revenue was $292.50 million, a decrease of -3.76% compared to the previous year's $303.91 million. Losses were -$33.99 million, -81.56% less than in 2024.

Financial numbers in USD